Rhizolutin, a Novel 7/10/6‐Tricyclic Dilactone, Dissociates Misfolded Protein Aggregates and Reduces Apoptosis/Inflammation Associated with Alzheimer's Disease
Lists
Only you see this
Abstract
Rhizolutin (1) was discovered as a natural product of ginseng-rhizospheric Streptomyces sp. WON17. Its structure features an unprecedented 7/10/6-tricyclic dilactone carbon skeleton composed of dimethylcyclodecatriene flanked by a 7-membered and a 6-membered lactone ring based on spectroscopic analysis. During an unbiased screening of natural product libraries, this novel compound was found to dissociate amyloid-β (Aβ) plaques and tau tangles, which are key pathological hallmarks of Alzheimer's disease (AD). Rhizolutin treatment of APP/PS1 double transgenic mice with AD significantly dissociated hippocampal plaques. In vitro, rhizolutin substantially decreased Aβ-induced apoptosis and inflammation in neuronal and glial cells. Our findings introduce a unique chemical entity that targets Aβ and tau concurrently by mimicking misfolded protein clearance mechanisms of immunotherapy, which is prominently investigated in clinical trials.
BibTeX
@inproceedings{kwon2020rhizolutin,
author = {Y.S. Kwon and Jisu Shin and Kwangho Nam and Joon Soo An and Seung‐Hoon Yang and Seong‐Heon Hong and Munhyung Bae and Kyuho Moon and Yakdol Cho and Jiwan Woo and Keunwan Park and Kyeonghwan Kim and Jongheon Shin and Byung‐Yong Kim and Young Soo Kim and Dong‐Chan Oh},
title = {{Rhizolutin, a Novel 7/10/6‐Tricyclic Dilactone, Dissociates Misfolded Protein Aggregates and Reduces Apoptosis/Inflammation Associated with Alzheimer's Disease}},
booktitle = {Angewandte},
year = {2020},
doi = {10.1002/anie.202009294},
}Loading related content...